$-2.07
(Market cap
$251 Mln
Revenue (TTM)
$6 Mln
P/E Ratio
137.5
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.2
-
Debt to Equity
0.3
-
Book Value
$0.7
-
EPS
$1.2
-
Face value
--
-
Shares outstanding
10,149,411
10 Years Aggregate
CFO
$-155.76 Mln
EBITDA
$-142.55 Mln
Net Profit
$-205.86 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
OpGen (OPGN)
| -- | -- | -- | -- | -25.2 | -62.7 | -64.5 |
|
BSE Sensex*
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
OpGen (OPGN)
| -85.1 | -85.9 | -51.0 | 80.5 | -95.7 | -72.0 | -83.8 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
OpGen (OPGN)
|
0.3 | 251.2 | 5.2 | 12.0 | -156.5 | 162.5 | 137.5 | 0.0 |
| 75.0 | 10,557.2 | 622.0 | -300.9 | -25.7 | -61.1 | -- | 17.3 | |
| 247.1 | 15,262.7 | 867.5 | 506.6 | -2.8 | -- | 28.1 | 26.9 | |
| 76.9 | 10,446.2 | 105.8 | -829.6 | -715.0 | -- | -- | 60.3 | |
| 50.2 | 12,605.5 | 2,375.5 | 833.4 | 40.8 | 40.7 | 16.6 | 6.4 | |
| 119.0 | 15,772.8 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 299.5 | 8,827.7 | 417.3 | 225.0 | 42.8 | 18.6 | 40 | 6.9 | |
| 517.3 | 11,925.8 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 22.0 | |
| 432.8 | 12,360.6 | 2,678.3 | 460.4 | 21.1 | 103.2 | 27.3 | 20.7 | |
| 343.6 | 9,578.0 | 0.0 | -326.5 | -- | -37.2 | -- | 6.8 |
Shareholding Pattern
View DetailsAbout OpGen (OPGN)
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application... cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland. Read more
-
Executive VP of Corporate Development
Dr. Oliver Schacht Ph.D.
-
Executive VP of Corporate Development
Dr. Oliver Schacht Ph.D.
-
Headquarters
Clarksburg, MD
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for OpGen (OPGN)
What is the current share price of OpGen Inc (OPGN) Today?
The share price of OpGen Inc (OPGN) is $0.33 (NASDAQ) as of 12-May-2026 09:30 EDT. OpGen Inc (OPGN) has given a return of -25.16% in the last 3 years.
What is the current PB & PE ratio of OpGen Inc (OPGN)?
The P/E ratio of OpGen Inc (OPGN) is 137.50 times as on 12-May-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
-0.02
|
-0.05
|
|
2022
|
0.00
|
0.01
|
|
2021
|
-0.01
|
0.00
|
What is the 52 Week High and Low of OpGen Inc (OPGN)?
The 52-week high and low of OpGen Inc (OPGN) are Rs 0.33 and Rs 0.33 as of 24-May-2026.
What is the market cap of OpGen Inc (OPGN)?
OpGen Inc (OPGN) has a market capitalisation of $ 251 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in OpGen Inc (OPGN)?
Before investing in OpGen Inc (OPGN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.